Barriers and pathways to development of Indigenous traditional medicines

本土传统药物发展的障碍和途径

• 批准号: IN220100031
• 负责人: Dr Virginia Marshall
• 金额: $ 72.65万
• 依托单位: The Australian National University
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Indigenous
• 财政年份: 2022
• 资助国家: 澳大利亚
• 起止时间: 2022-09-13 至 2025-09-12
• 项目状态: 未结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/IN220100031
• 关键词: Barriers; pathways; development; Indigenous; traditional

This project aims to explore how Australian regulatory systems can better support Aboriginal and Torres Strait Islander Traditional Knowledge (TK) holders to commercialise their traditional medicines. Focusing on the mudjala plant and working with the Kimberley’s Nyikina people, the project should generate new anthropological methods for documenting TK related to traditional medicine, new models for regulating traditional medicinal products, and pharmacological insights into traditional methods of activating the plant. Additional expected outcomes include unlocking the significant, untapped potential for Indigenous Australians to benefit from the development of traditional medicine products regulated by the Therapeutic Goods Administration.

该项目旨在探讨澳大利亚的监管制度如何能够更好地支持土著和托雷斯海峡岛民传统知识的持有者将其传统药物商业化。该项目以mudjala植物为重点，并与金伯利的Nyikina人合作，将产生新的人类学方法，记录与传统医药有关的传统知识，管理传统医药产品的新模式，以及对激活植物的传统方法的药理学见解。其他预期成果包括释放澳大利亚土著人尚未开发的巨大潜力，使其受益于治疗用品管理局监管的传统医药产品的开发。